The Best Text-to-Speech Apps and Tools for 2025 Reading is great, but sometimes you want or need to listen. Let your computer or phone read aloud to you with the top text-to-speech software for ...

Sampaio, A. , Figueiras, J. and Gomes, A. (2025) BIM Applied to Bridges: Single-Cell Box Deck Modelling Supported by Dynamo ...

Presented new positive data of ERNA-101 for PROC in ASCO-2025, AACR-2025 annual meetings, demonstrating how ERNA-101 addresses a significant unmet need with rapid disease progression, poor outcomes, ...

Düsseldorf, Germany, November 4, 2025 – Abalos Therapeutics announced today that it will present new preclinical data on the development of ABX-001 and its potential to further intensify anti-tumoral ...

BURLINGTON, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Abpro Corporation (Nasdaq: ABP) (“Abpro”) and Celltrion, Inc. (“Celltrion”) today announced that they will present new preclinical data for ...

“We continue to operate with financial discipline, focusing our resources on advancing our cell therapy programs toward the clinical stage,” said Sanjeev Luther, President and CEO of Ernexa ...

CT-P72/ABP-102 poster selected as one of the Top 150 abstracts out of more than 1,300 submissions at SITC 2025 CT-P72/ABP-102 demonstrates potent and selective anti-tumor activity in HER2-high models, ...

The Company’s operating loss declined by 44% year-over-year, reflecting its continued laser focus on relentless execution and progress in operational excellence Continued progress with lead program, ...

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (OTC PINK: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company pursuing new ...

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (OTC PINK: CERO) ("CERo” or the "Company”), an innovative cellular immunotherapy company pursuing new ...